share_log

POINT Biopharma Completes Randomization In PNT2002's Phase 3 SPLASH Trial

Benzinga Real-time News ·  Jan 12, 2023 08:43
POINT Biopharma Completes Randomization In PNT2002's Phase 3 SPLASH Trial
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment